Should ultra-short course RT be standard for elderly or poor performance status patients with glioblastoma?  

The recent Roa trial (JCO 9/21/15) found that 25Gy/5fx was non-inferior to 40Gy/5fx in terms of OS, PFS, and QOL. Is 25Gy in 5 daily fractions an appropriate treatment in older and/or poor PS patients?



Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Community Practice

Answer from: Radiation Oncologist at Community Practice